(Q33684379)

28 July 2017

Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype (English)

1 reference

28 July 2017

1 reference

Jeff Skinner

7

0 references

Hiroshi Yamazaki

object named as

Hiroshi Yamazaki

2

0 references

Norie Murayama

3

object named as

Norie Murayama

1 reference

28 July 2017

1

Dimitrios Zonios

1 reference

28 July 2017

Ven Natarajan

4

1 reference

28 July 2017

Tara Palmore

5

1 reference

28 July 2017

Richard Childs

6

1 reference

28 July 2017

John E Bennett

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

7 January 2014

1 reference

Journal of Infectious Diseases

28 July 2017

1 reference

28 July 2017

209

1 reference

28 July 2017

12

1 reference

28 July 2017

1941-1948

1 reference

Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Pharmacogenomics of the triazole antifungal agent voriconazole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Hallucinations during voriconazole therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Pharmacokinetic/pharmacodynamic profile of voriconazole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Discovery of new potentially defective alleles of human CYP2C9.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038142

Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24403552

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIU017

1 reference

28 July 2017

1 reference

28 July 2017

1 reference